The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) manages our nation’s investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment and medical countermeasures.

The JPEO-CBRND leads, manages, and directs the acquisition, fielding and sustainment of CBRN sensors, protective equipment, medical countermeasures, information management systems, defense enabling biotechnologies, and specialized equipment for U.S. Special Forces. The organization also works closely with various government agencies that need CBRN defense equipment. Learn more about the Joint Project Management Offices for CBRN Protection, CBRN Medical, and CBRN Sensors.

Learn more about the JPEO-CBRND

Our Mission

Protect the Joint Force from weapons of mass destruction by generating affordable capabilities.

Our Vision

A resilient Joint Force enabled to fight and win unencumbered by a chemical, biological, radiological, or nuclear environment; championed by innovative, agile, results-oriented acquisition professionals.

Partnering Benefits


Work with the JPEO-CBRND on providing solutions that protect the Joint Force and the Warfighter from weapons of mass destruction. Help us achieve our vision of a resilient Joint Force that's enabled to fight and win unencumbered by CBRN environments.

Innovative Contracting Experience iconInnovative Contracting Experience

Our Other Transactional Authority (OTA) agreements enable enhanced communications and support innovation. 

Agile Execution iconAgile Execution

We face a complex threat environment, so we need the partnership and support of industry and academia to help us innovate at the speed of relevancy for our current CBRN defense environments.

Share iconShare Your Latest Insights with Government

The JPEO-CBRND is eager to learn more about the latest innovations, capabilities and insights to help support the Joint Force and protect our Warfighters. 

Keep Current iconKeep Current on the CBRND Industrial Base’s Needs

Gain insight into the way ahead for our organization as well as our CBRND partners.

Modernize iconHelp Modernize the Joint Force 

Help establish and refine the long-term vision for CBRND capabilities.

Speed iconDevelopment at the Speed of Relevancy

Help the JPEO-CBRND tackle the R&D needs on the horizon and learn more about our “new start” programs here.

Featured Technologies

Joint Service General Purpose Mask (JSGPM)

Joint Service General Purpose Mask (JSGPM)


Next Generation Diagnostics System 1 (NGDS 1)

Next Generation Diagnostics System 1 (NGDS 1)


Nuclear, Biological, Chemical Reconnaissance Vehicle

Nuclear, Biological, Chemical Reconnaissance Vehicle (NBCRV)



American flags against a blue sky background

Biden Administration announces U.S. government procurement of Merck’s investigational antiviral medicine for COVID-19 treatment

Jun. 09, 2021

The Biden Administration today announced that the U.S. government will procure approximately 1.7 million...
Read More
COVID-19 vaccine rollout ongoing in U.S. Army Central footprint

DOD & HHS Announce DPA Title III Agreement With Retractable Technologies, Inc. to Expand Domestic Production Capacity for Low Dead-Space Safety Syringes and Needles

May. 24, 2021

As part of the national response to COVID-19, the Department of Defense (DOD), in coordination with the...
Read More
A servicemember sits in a yellow shirt in front of a table of red and blue testing vials. Covi

Sanofi-GSK report positive interim results for their COVID-19 shot

May. 17, 2021

An experimental COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in...
Read More
In the foreground a hand holding an orange sticker that says "I got my vaccine". In the background there are three medical personnel wearing personal protective equipment.

INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

May. 10, 2021

INO-4800 was shown to be safe, well-tolerated and immunogenic in all age groups. Phase 2 results informed...
Read More
American flags against a blue sky background

Memorandum of Understanding for Acquisition Support Signed Between the Department of Defense and the Department of Health and Human Services

May. 26, 2021

On May 20, 2021, Deputy Secretary of Defense Kathleen Hicks and Deputy Secretary of Health and Human Services...
Read More
Two lab technicians dress in PPE

JPEO-CBRND, JPM CBRN Medical Leads DOD Ebola Outbreak Response Efforts

Apr. 28, 2021

DISCLAIMER: Included references to commercial products does not constitute endorsement by the U.S. Department...
Read More
Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

SAB Biotherapeutics Doses First Patient with SAB-185 for the Treatment of COVID-19 in NIH’s ACTIV-2 Phase 2/3 Clinical Trial

Apr. 21, 2021

Read More
The South Carolina National Guard Medical Command receives its first shipment of COVID-19 Moderna vaccinations at McEntire Joint National Guard Base, South Carolina, Dec. 22, 2020. The South Carolina National Guard is a Moderna Department of Defense (DoD) vaccine pilot program state and is provided a limited DoD allocation for South Carolina National Guard Soldiers and Airmen to have the opportunity to voluntarily take the vaccine. The South Carolina National Guard remains ready to support the counties, local and state agencies and first responders with requested resources for as long as needed in support of COVID-19 response efforts in the state.

Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna

Feb. 12, 2021

FOR IMMEDIATE RELEASE - The U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD)...
Read More
Compassionate care nurses

DOD Awards Industry Partner Immunome $13.3 Million for Biosynthetic Convalescent Plasma Development

Feb. 11, 2021

The JPM CBRN Medical leveraged an industry partnership to accelerate COVID-19 prevention and treatment...
Read More

Where to Find Us

National Defense Industrial Association (NDIA) CBRN Defense Conference
May 3, 2021 - August 16–18, 2021Responding Now – Preparing for Future CBRN Threats.Baltimore, MD (In Person)Learn More

CBRNe Convergence 2021
May 3, 2021 - November 2, 2021Annual conference and exhibition hosted by CBRNe World.Orlando, FL (In Person)Learn More

CBRNe Summit USA
May 3, 2021 - October 12-14, 2021Gathering of military and civil officials who deal with CBRNe incidents. Las Vegas, NVLearn More 

NCT Europe
May 3, 2021 - October 5-7, 2021Connecting the European CBRNe Community.Rieti, Italy (In Person & Virtual)Learn More
The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. Government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.